We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Rule on Reporting Adverse Events Should Reduce Overreporting of Data
New Rule on Reporting Adverse Events Should Reduce Overreporting of Data
September 29, 2010
To reduce the overreporting of adverse events in drug trials, the FDA has issued a final rule that clarifies when and what events sponsors should report.